Answers are grounded in this paper and cite their sources.
Investigates GPR17 activation's impact on neuroinflammation and neurological function in neonatal rat GMH model, suggesting novel therapeutic pathways.
Germinal matrix hemorrhage (GMH), a major complication of prematurity, involves severe neuroinflammation leading to neurological deficits. While G protein-coupled receptor 17 (GPR17) is known to modulate neuroinflammation, its therapeutic potential in GMH remains unexplored. This study investigated the anti-inflammatory effects and mechanisms of GPR17 activation in a neonatal rat GMH model induced by collagenase injection. Pre-treatment with the GPR17 agonist MDL-29951 was found to upregulate GPR17, downregulate cleaved Caspase-3, IL-1β, and TNF-α, and reduce apoptosis and glial infiltration at 1 day post-GMH. The treatment also improved neurological function, inhibited IκBα degradation and p65 nuclear translocation, and preserved white matter (WM) integrity. In vitro, GPR17 functioned as a negative regulator of the NF-κB pathway in primary microglia. These results suggest that GPR17 activation alleviates neuroinflammation and improves neurological outcomes after GMH, at least in part through attenuation of the NF‑κB pathway.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: